Kate is a former chef turned financial writer and editor, with more than 15 years of market experience. After working as a healthcare analyst in the '00s, when IPOs became an endangered species, she moved into general editorial, but healthcare/biotech remains her primary area of interest.
Kate is a former chef turned financial writer and editor, with more than 15 years of market experience. After working as a healthcare analyst in the '00s, when IPOs became an endangered species, she moved into general editorial, but healthcare/biotech remains her primary area of interest.
less
